Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Chronic Lymphocytic Leukemia

Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation

Abstract

Chronic lymphocytic leukemia (CLL) is an indolent B-cell non-Hodgkin's lymphoma that may transform into higher-grade lymphoma. The transformation involves an increased number of prolymphocytic cells, termed prolymphocytic transformation (PLT) or the development of diffuse large B-cell lymphoma (DLBL), also referred to as Richter's transformation (RT). To analyze whether activation-induced cytidine deaminase (AID), which is essential for somatic hypermutation (SHM) of normal B-cells, and malfunction of SHM termed aberrant somatic hypermutation (ASHM) are associated with higher-grade transformation of CLL, AID mRNA expression and the mutation pattern of c-MYC, PAX-5 and RhoH genes were analyzed in eight cases of CLL without transformation and in 21 cases that showed RT or PLT. Chronic lymphocytic leukemia cases, which showed no transformation or eventually transformed into higher-grade lymphoma, showed low levels of AID mRNA expression and low frequency of mutations of c-MYC, PAX-5 and RhoH genes. In both RT and PLT, high-levels of AID mRNA expression and high-frequency mutations of c-MYC, PAX-5 and RhoH genes were detected. These results indicate that AID expression and ASHM are associated with higher-grade transformation of CLL and provide further evidences that AID expression and ASHM may be activated during the clonal history of B-cell lymphomas.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Richter M . Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. Am J Pathol 1928; 68: 368–373.

    Google Scholar 

  2. Foucar K, Rydell RE . Richter's syndrome in chronic lymphocytic leukemia. Cancer 1980; 46: 118–134.

    Article  CAS  PubMed  Google Scholar 

  3. Jaffe ES, Harris NL, Stein H, Vardiman JW . Pathology and genetics of tumours of haemopoetic and lymphoid tissues. In: Banks PM, Warnke RA (eds). World Health Organization Classification of Tumours. IARC Press: Lyon, 2001.

    Google Scholar 

  4. Tsimberidou AM, Keating MJ . Richter syndrome. Cancer 2005; 103: 216–228.

    Article  CAS  PubMed  Google Scholar 

  5. Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Küppers R et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001; 412: 341–346.

    Article  CAS  PubMed  Google Scholar 

  6. Gaidano G, Pasqualucci L, Capello D, Berra E, Deambrogi C, Rossi D et al. Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. Blood 2003; 102: 1833–1841.

    Article  CAS  PubMed  Google Scholar 

  7. Montesinos-Rongen M, Van Roost D, Schaller C, Wiestler OD, Deckert M . Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation. Blood 2004; 103: 1869–1875.

    Article  CAS  PubMed  Google Scholar 

  8. Bödör CS, Bognár Á, Reiniger L, Szepesi Á, Tóth E, Kopper L et al. Aberrant somatic hypermutation and expression of activation-induced cytidine deaminase mRNA in mediastinal large B-cell lymphoma. Br J Haematol 2005; 129: 373–376.

    Article  PubMed  Google Scholar 

  9. Libra M, Capello D, Gloghini A, Laura P, Berra E, Cerri M et al. Analysis of aberrant somatic hypermutation (SHM) in non-Hodgkin's lymphomas of patients with chronic HCV infection. J Pathol 2005; 206: 87–91.

    Article  CAS  PubMed  Google Scholar 

  10. Kuppers R, Klein U, Hansmann ML, Rajewski K . Cellular origin of human B-cell lymphomas. N Engl J Med 1999; 341: 1520–1529.

    Article  CAS  PubMed  Google Scholar 

  11. Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, Davidson NO et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA editing deaminase family in germinal center B cells. J Biol Chem 1999; 274: 18470–18476.

    Article  CAS  PubMed  Google Scholar 

  12. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T . Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000; 102: 553–563.

    Article  CAS  PubMed  Google Scholar 

  13. Okazaki I, Hiai H, Kakazu N, Yamada S, Muramatsu M, Kinoshita K et al. Constitutive expression of AID leads to tumorigenesis. J Exp Med 2003; 197: 1173–1181.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kuppers R, Goossens T, Klein U . The role of somatic hypermutation in the generation of deletions and duplications in human Ig V region genes and chromosomal translocations. Curr Top Microbiol Immunol 1999; 246: 193–198.

    CAS  PubMed  Google Scholar 

  15. Csernus B, Timár B, Fülöp Z, Bognár A, Szepesi A, László T et al. Mutational analysis of IgVH and BCL-6 genes suggests thymic B-cell origin of mediastinal B-cell lymphoma. Leuk Lymphoma 2004; 45: 2105–2110.

    Article  CAS  PubMed  Google Scholar 

  16. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840–1847.

    CAS  PubMed  Google Scholar 

  17. Albesiano E, Messmer BT, Damle RN, Allen SL, Rai KR, Chiorazzi N . Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone. Blood 2003; 102: 3333–3339.

    Article  CAS  PubMed  Google Scholar 

  18. Cerutti A, Zan H, Kim EC, Shah S, Schattner EJ, Schaffer A et al. Ongoing in vivo immunoglobulin class switch DNA recombination in chronic lymphocytic leukemia B cells. J Immunol 2002; 169: 6594–6603.

    Article  CAS  PubMed  Google Scholar 

  19. Smit LA, Bende RJ, Aten J, Guikema JE, Aarts WM, van Noesel CJ . Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. Cancer Res 2003; 63: 3894–3898.

    CAS  PubMed  Google Scholar 

  20. Greeve J, Philipsen A, Krause K, Klapper W, Heidorn K, Castle BE et al. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood 2003; 101: 3574–3580.

    Article  CAS  PubMed  Google Scholar 

  21. Oppezzo P, Dumas G, Lalanne AI, Payelle-Brogard B, Magnac C, Pritsch O et al. Different isoforms of BSAP regulate expression of AID in normal and chronic lymphocytic leukemia B cells. Blood 2005; 105: 2495–2503.

    Article  CAS  PubMed  Google Scholar 

  22. Guikema JE, Rosati S, Akkermans K, Bende RJ, van Noesel CJ, van Krieken JH et al. Quantitative RT-PCR analysis of activation-induced cytidine deaminase expression in tissue samples from mantle cell lymphoma and B-cell chronic lymphocytic leukemia patients. Blood 2005; 105: 2997–2998; discussion 2998–2999.

    Article  CAS  PubMed  Google Scholar 

  23. Lossos IS, Levy R, Alizadeh AA . AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity. Leukemia 2004; 18: 1775–1779.

    Article  CAS  PubMed  Google Scholar 

  24. Timar B, Fulop Z, Csernus B, Angster C, Bognar A, Szepesi A et al. Relationship between the mutational status of VH genes and pathogenesis of diffuse large B-cell lymphoma in Richter's syndrome. Leukemia 2004; 18: 326–330.

    Article  CAS  PubMed  Google Scholar 

  25. Nilsen H, An Q, Lindahl T . Mutation frequencies and AID activation state in B-cell lymphomas from Ung-deficient mice. Oncogene 2005; 24: 3063–3066.

    Article  CAS  PubMed  Google Scholar 

  26. Oppezzo P, Vuillier F, Vasconcelos Y, Dumas G, Magnac C, Payelle-Brogard B et al. Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation. Blood 2003; 101: 4029–4032.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the Hungarian Ministry of Health ETT 144/2003 and 147/2003, and from the Hungarian Scientific Research Foundation OTKA T032572, T034410 and TS49887.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A Matolcsy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reiniger, L., Bödör, C., Bognár, Á. et al. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation. Leukemia 20, 1089–1095 (2006). https://doi.org/10.1038/sj.leu.2404183

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404183

Keywords

This article is cited by

Search

Quick links